[New data on the pathogenesis of steroid-induced osteoporosis: consequences for therapy and prevention].
Hüfner
M
M
Schwerpunkt Endokrinologie, Abteilung Gastroenterologie und Endokrinologie, Medizinische Universitätsklinik, Zentrum Innere Medizin, Georg-August-Universität, Göttingen. mhuefner@med.uni-goettingen.de
Siggelkow
H
H
D000305:Adrenal Cortex Hormones / Q000009:adverse effects*; D000308:Adrenocortical Hyperfunction / Q000139:chemically induced / Q000150:complications*; D000368:Aged; D015519:Bone Density / Q000187:drug effects*; D002118:Calcium / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003480:Cushing Syndrome / Q000150:complications* / Q000188:drug therapy; D004164:Diphosphonates / Q000627:therapeutic use; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000139:chemically induced* / Q000188:drug therapy; D014807:Vitamin D / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D004164:Diphosphonates; D005938:Glucocorticoids; D014807:Vitamin D; D002118:Calcium